Researcher:
Kaban, Kerim

Profile Picture
ORCID

Job Title

Doctor

First Name

Kerim

Last Name

Kaban

Name

Name Variants

Kaban, Kerim

Email Address

Birth Date

Filters

2019 - 201912020 - 20211

Advanced Search

Filter by

Settings

Researcher Of Publications: search.filters.isAuthorOfPublication.ada2e7f9-fa02-488a-a749-f5af9ba65640

Search Results

Now showing 1 - 2 of 2
  • Placeholder
    PublicationMetadata only
    Primary retroperitoneal müllerian adenocarcinoma: report of two cases treated with radical surgery
    (Elsevier Inc., 2021) Vatansever, Doğan; Mısırlıoğlu, Selim; Bölükbaşı, Yasemin; Taşkıran, Çağatay; Arslan, Tonguç; Zeren, Emine Handan; Cihangir, Çelik; Kaban, Kerim; Faculty Member; Doctor / Faculty Member; Faculty Member; Faculty Member; Doctor; Doctor; Doctor; School of Medicine; Koç University Hospital / School of Medicine; School of Medicine; School of Medicine; N/A; N/A; N/A; Koç University Hospital; 193687; N/A; 216814; 134190; N/A; N/A; N/A
    Background: Primary retroperitoneal Müllerian adenocarcinoma (PRMA) is a very rare type of primary retroperitoneal tumour. Case 1: A 45-year-old woman presented with left lower extremity swelling and pain. Imaging revealed that the tumour had invaded the left common iliac vein and artery, internal and external iliac arteries, sciatic and obturator nerves, and pelvic wall. Case 2: A 37-year-old was admitted with pelvic pain. Imaging showed the tumor at the left iliac bifurcation infiltrating the internal iliac artery and left sciatic, obturator, and femoral nerves. Both of these patients were treated with radical surgery that achieved no visible tumour at the end of the operation. Conclusion: There is no guideline for the diagnosis and management of this entity due to its rarity. These cases should be managed at highly specialized centres with expertise in radical surgery.
  • Thumbnail Image
    PublicationOpen Access
    Dealing with the gray zones in the management of gastric cancer: the consensus statement of the İstanbul Group
    (Aves, 2019) Aytaç, Erman; Çiçek, Bahattin; Erdamar, Sibel; Güven, Koray; Karahasanoğlu, Tayfun; Atalar, Banu; Tozun, Nurdan; Arıcan, Ali; Hamzaoğlu, İsmail; Baca, Bilgi; Saruç, Murat; Göksel, Süha; Demir, Gökhan; Ağaoğlu, Fulya; Yakıcıer, Cengiz; Özbek, Uğur; Özben, Volkan; Özyar, Enis; Güner, Ahmet Levent; Er, Özlem; Bölükbaşı, Yasemin; The İstanbul Group; N/A; N/A; N/A; N/A; N/A; Gürses, Bengi; Falay, Fikri Okan; Selçukbiricik, Fatih; Rozanes, İzzet; Mamuş, Ayşe Ezgi; Buğra, Dursun; Aslan, Fatih; Kaban, Kerim; Faculty Member; Teaching Faculty; Faculty Member; Faculty Member; Faculty Member; Faculty Member; School of Medicine; N/A; N/A; N/A; N/A; 27211; N/A; N/A; N/A; N/A
    The geographical location and differences in tumor biology significantly change the management of gastric cancer. The prevalence of gastric cancer ranks fifth and sixth among men and women, respectively, in Turkey. The international guidelines from the Eastern and Western countries fail to manage a considerable amount of inconclusive issues in the management of gastric cancer. The uncertainties lead to significant heterogeneities in clinical practice, lack of homogeneous data collection, and subsequently, diverse outcomes. The physicians who are professionally involved in the management of gastric cancer at two institutions in Istanbul, Turkey, organized a consensus meeting to address current problems and plan feasible, logical, measurable, and collective solutions in their clinical practice for this challenging disease. The evidence-based data and current guidelines were reviewed. The gray zones in the management of gastric cancer were determined in the first session of this consensus meeting. The second session was constructed to discuss, vote, and ratify the ultimate decisions. The identification of the T stage, the esophagogastric area, imaging algorithm for proper staging and follow-up, timing and patient selection for neoadjuvant treatment, and management of advanced and metastatic disease have been accepted as the major issues in the management of gastric cancer. The recommendations are presented with the percentage of supporting votes in the results section with related data.